Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial)
Critical Care2012Vol. 16(6), pp. R231–R231
Citations Over TimeTop 10% of 2012 papers
Jaimin Patel, Catherine Snaith, David Thickett, Lucie Linhartová, Teresa Melody, Peter M. Hawkey, Anthony Barnett, Alan Jones, Tan Hong, Matthew W Cooke, Gavin D. Perkins, Fang Gao
Abstract
International Standard Randomized Control Trial Registry ISRCTN64637517.
Related Papers
- → Effect of atorvastatin on hs‐CRP in acute coronary syndrome(2008)11 cited
- → More support for high-dose atorvastatin in coronary artery disease(2005)
- Effect of Atorvastatin on Endothelial Function in Hypertensives Without Hyperlipemia(2007)
- Anti-inflammatory effects of atorvastatin on patients with acute coronary syndrome(2006)
- The Effect of Atorvastatin on the Plasma Hydrogen Sulfide and Nitric Oxide Levels in Patients with Essential Hypertension(2013)